Mai Capital Management Takeda Pharmaceutical CO LTD Transaction History

Mai Capital Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $311,900 - $330,270	-19,135 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$16.55 - $18.64 $29,243 - $32,936	-1,767 Reduced 8.45%	19,135 $322,000
Q1 2021 May 10, 2021	BUY	$16.71 - $19.9 $9,875 - $11,760	591 Added 2.91%	20,902 $382,000
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $14,112 - $17,395	-917 Reduced 4.32%	20,311 $370,000
Q3 2020 Oct 26, 2020	SELL	$17.1 - $19.19 $6,344 - $7,119	-371 Reduced 1.72%	21,228 $379,000
Q2 2020 Jul 27, 2020	SELL	$14.59 - $19.5 $38,050 - $50,856	-2,608 Reduced 10.77%	21,599 $387,000
Q1 2020 Apr 16, 2020	BUY	$13.02 - $20.31 $8,957 - $13,973	688 Added 2.93%	24,207 $367,000
Q4 2019 Feb 03, 2020	BUY	$16.88 - $20.83 $397,000 - $489,900	23,519 New	23,519 $464,000
Q3 2019 Oct 29, 2019	SELL	$16.15 - $17.99 $193,380 - $215,412	-11,974 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$16.58 - $20.49 $29,661 - $36,656	-1,789 Reduced 13.0%	11,974 $212,000
Q1 2019 Apr 29, 2019	BUY	$16.7 - $21.52 $229,842 - $296,179	13,763 New	13,763 $280,000

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.